Thrombosis Evaluation
How to Evaluate Thrombosis on Vascular Devices
Thrombosis evaluation is an important consideration for many vascular medical devices. When a device contacts blood, the surface can interact with platelets, plasma proteins, coagulation pathways, and flow conditions that may contribute to thrombus formation.
For device developers, thrombosis evaluation is not a single test. It is a strategy that may include material characterization, coating evaluation, flow-based testing, imaging, biochemical endpoints, and comparison to appropriate controls.
Why Vascular Devices Require Device-Specific Evaluation
Vascular devices often have complex geometries and demanding use environments. Thrombus formation may be influenced by surface chemistry, device design, flow disturbance, blood residence time, local shear, material roughness, exposed edges, and coating uniformity.
Examples of vascular devices that may require thrombosis-related evaluation include:
Stents
Covered stents
Vascular grafts
Catheters
Embolic protection devices
Blood filters
Thrombectomy devices
Anastomosis devices
Vascular access devices
Mechanical circulatory support components
Common Evaluation Approaches
Thrombosis evaluation may include several complementary methods:
Surface characterization
Assessment of coating coverage, surface chemistry, roughness, thickness, and uniformity.
Dynamic blood exposure testing
Circulation of whole blood through a loop or flow model to evaluate thrombus formation under controlled flow conditions.
Visual and image-based assessment
Inspection of device surfaces after blood exposure to identify clot accumulation, regional differences, or geometry-related effects.
Biochemical analysis
Measurement of fibrin, platelet-related markers, hemolysis markers, or coagulation-related endpoints.
Comparative testing
Testing coated and uncoated devices under matched conditions to evaluate the effect of the surface treatment.
Importance of Controls
Controls are essential for interpreting thrombosis results. A study may include an uncoated device, a known reference material, a predicate surface, or a coating control. Controls help distinguish whether observed effects are due to the coating, device geometry, base material, or test system.
For coating development, one of the most informative comparisons is often a coated device vs. the same uncoated device tested under identical conditions.
Role of Flow Conditions
Flow can strongly influence thrombus formation. Regions of low flow, recirculation, stagnation, or high shear may behave differently than smooth, uniform flow regions. For this reason, vascular device thrombosis testing should consider how the device is positioned, how blood moves through or around the device, and whether the test setup reasonably represents the development question.
Coating Considerations
When evaluating a coated vascular device, testing should consider both biological response and coating quality. A coating that performs well on a flat coupon may behave differently on a finished device with struts, pores, edges, joints, lumens, or complex surfaces.
Important coating-related questions include:
Is the coating present on relevant blood-contacting surfaces?
Is the coating uniform enough for the intended application?
Does the coating remain intact after handling or simulated use?
Does the coating generate particulate?
Does the coating change the thrombus response compared with the uncoated device?
How Alta Biomed Supports Vascular Device Thrombosis Evaluation
Alta Biomed supports thrombosis-related evaluation through PzF coating development, coated vs. uncoated device comparisons, surface inspection, and dynamic blood loop testing. Our work is designed to help vascular device developers understand how surface modification may influence blood-contacting performance during feasibility and development.
Developing a Vascular Device?
Contact Alta Biomed to discuss thrombosis evaluation and coating feasibility.
6070 Corte Del Cedro, Unit A
Carlsbad, CA 92011